Does McGrath RentCorp's (NASDAQ:MGRC) 22% Earnings Growth Make It An Outperformer?

Measuring McGrath RentCorp's (NasdaqGS:MGRC) track record of past performance is an insightful exercise for investors. It enables us to reflect on whether the company has met or exceed expectations, which is a powerful signal for future performance. Below, I will assess MGRC's recent performance announced on 31 December 2019 and compare these figures to its historical trend and industry movements.

See our latest analysis for McGrath RentCorp

Advertisement

How Well Did MGRC Perform?

MGRC's trailing twelve-month earnings (from 31 December 2019) of US$97m has jumped 22% compared to the previous year.

However, this one-year growth rate has been lower than its average earnings growth rate over the past 5 years of 25%, indicating the rate at which MGRC is growing has slowed down. What could be happening here? Well, let's examine what's transpiring with margins and whether the whole industry is feeling the heat.

NasdaqGS:MGRC Income Statement, March 19th 2020
NasdaqGS:MGRC Income Statement, March 19th 2020

In terms of returns from investment, McGrath RentCorp has fallen short of achieving a 20% return on equity (ROE), recording 15% instead. However, its return on assets (ROA) of 8.3% exceeds the US Commercial Services industry of 6.0%, indicating McGrath RentCorp has used its assets more efficiently. And finally, its return on capital (ROC), which also accounts for McGrath RentCorp’s debt level, has increased over the past 3 years from 7.5% to 12%. This correlates with a decrease in debt holding, with debt-to-equity ratio declining from 76% to 46% over the past 5 years.

What does this mean?

Though McGrath RentCorp's past data is helpful, it is only one aspect of my investment thesis. Positive growth and profitability are what investors like to see in a company’s track record, but how do we properly assess sustainability? I recommend you continue to research McGrath RentCorp to get a better picture of the stock by looking at:

  1. Future Outlook: What are well-informed industry analysts predicting for MGRC’s future growth? Take a look at our free research report of analyst consensus for MGRC’s outlook.
  2. Financial Health: Are MGRC’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.
  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

NB: Figures in this article are calculated using data from the trailing twelve months from 31 December 2019. This may not be consistent with full year annual report figures.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

MI
mitchell_lawler
mitchell_lawler

A landmark settlement is meant to punish Meta (META). If the 1998 tobacco deal is any guide, it might protect it.

A landmark settlement is meant to punish Meta (META). If the 1998 tobacco deal is any guide, it might protect it. cover
77
ZO
zoe_vi5fn

Any moat with an opt-out clause for your competitors is just a fence around your own garden.

CO
connor_iwn1g

Worth looking at what previous legal action actually did to Meta rather than reaching for tobacco. The FTC's record five billion dollar privacy fine in 2019 was met with the stock rising, because it came in below fears and removed an open question. GDPR was designed to constrain large platforms and increased their share of the European ad market, because compliance cost fell hardest on small intermediaries. The FTC's antitrust case, the one that could genuinely have broken the company up, was decided in Meta's favour last November. The only thing that ever meaningfully hurt the business was Apple changing a tracking default, and Meta out-spent that too, while the ad-tech firms that could not afford to rebuild disappeared. The pattern is not that Meta survives regulation. It is that regulation keeps costing its smaller competitors more.

Andrew Legget

Great earnings season, but are the earnings real?

Great earnings season, but are the earnings real? cover
At first glance, this was the strongest earnings season in years. But when you look at where the growth actually came from, the story splits into two very different pictures.
00

About NasdaqGS:MGRC

McGrath RentCorp

Operates as a business-to-business rental company in the United States and internationally.

Very undervalued established dividend payer.

Advertisement

Weekly Picks

LO
Lou_Basenese
ONCY logo
Lou_Basenese on Oncolytics Biotech ·

The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech

Fair Value:US$3.575.7% undervalued
22 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
TR
tripledub
Recommended Voice
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$5862.5% undervalued
58 users have followed this narrative
3 users have commented on this narrative
34 users have liked this narrative
TA
Talos
Emerging Author
VOYG logo
Talos on Voyager Technologies ·

The "Landlord of Orbit" – A Deep Value Play Ahead of the Starlab Era

Fair Value:US$385.291.0% undervalued
56 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
IV
Emerging Author
UBER logo
Ivoed on Uber Technologies ·

Uber’s Valuation Depends On Who Captures The Economics Of Driverless Rides

Fair Value:US$11633.7% undervalued
12 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

LI
PEP logo
Lijo on PepsiCo ·

A classic growth and income compounder

Fair Value:US$116.4720.0% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
RO
RockeTeller
BPAG logo
RockeTeller on BP Silver ·

BP Silver: 1,655 g/t Silver Hit + Phase 2 Underway, Is This $82M Market Cap the Next Bolivian Monster?

Fair Value:CA$132.8499.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TH
TheFutureOfValue
GQG logo
TheFutureOfValue on GQG Partners ·

Structural Resilience and Alpha Architecture: Why GQG Partners Represents an ASX Blue Chip Stock of the Future

Fair Value:AU$5.2474.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28018.6% undervalued
365 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9120.3% overvalued
213 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0946.1% undervalued
237 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative

Trending Discussion

AL
BUSER logo
AlfredB on Bambuser ·

Very Intresting Times for Bambuser

1
|
0
TT
6831 logo
TThe on Green Tea Group ·

Green tea dropped so much today

0
|
0
TE
HALO logo
Teg on Halozyme Therapeutics ·

You left out SnapShot.

0
|
0